Huntsman Cancer Institute at the University of Utah | Strategic Alliance Partners

Huntsman Cancer Institute at the University of Utah is a nationally recognized research center and treatment hospital in Salt Lake City. We are the only National Cancer Institute-designated Comprehensive Cancer Center in the Mountain West and serve patients with all types of cancer from Utah, Idaho, Montana, Nevada, and Wyoming. In 2021, we opened the region’s first proton therapy center. We manage the Utah Population Database, the largest genetic database in the world. More genes for inherited cancers have been discovered at our institution than any place in the world, including genes for melanoma and breast, ovarian, colon, head, and neck cancers.

Connect with us:

Latest from Huntsman Cancer Institute at the University of Utah

New Angio-CT Technology Integrates Cutting-Edge Imaging to Enhance Patient Care

November 18, 2025

Article

The new angiography-CT suite at Huntsman Cancer Institute is a regional first, expanding advanced interventional radiology capabilities in the Mountain West.

Study Links Obesity-Driven Fatty Acids To Breast Cancer, Warns Against High-Fat Diets Like Keto

October 22, 2025

Article

A study suggests that breast cancer patients with obesity could benefit from lipid lowering therapies and should avoid high-fat weight loss regimens.

Pinpointing Pivotal Prostate Cancer Data With Drs Agarwal and Shore

October 21, 2025

Video

Neeraj Agarwal, MD, FASCO, and Neal Shore, MD, FACS, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in prostate cancer presented during the 2025 ESMO Congress.

Ulrich Named President-Elect of AACI

October 10, 2025

Article

Neli Ulrich, PhD, MS, has been elected by the members of the Association of American Cancer Institutes to serve as vice president/president-elect of the AACI Board of Directors.

Huntsman Cancer Institute Earns Several Accolades for Quality of Cancer Care Programs and Facilities

September 12, 2025

Article

Huntsman Cancer Institute has been listed 10th among the top 75 cancer care hospitals in the US.

Dr Tashi on Differentiating Characteristics of Elenestinib in Indolent Systemic Mastocytosis

September 05, 2025

Video

Tsewang Tashi, MD, discusses the aspects of elenestinib that differentiate it from avapritinib in the management of indolent systemic mastocytosis.

Leaders Drive Theranostics Expansion to Transform Cancer Care

August 20, 2025

Article

Huntsman Cancer Institute has announced leadership team appointments overseeing clinical and research efforts in theranostics.

Proton Therapy Center Expansion Will Significantly Boost Patient Capacity Across the Mountain West

August 14, 2025

Article

Huntsman Cancer Institute is expanding its proton therapy center, enhancing access to advanced cancer treatment for patients in the Mountain West region.

$31 Million Pledged to Establish the Sigma Chi Center for Advanced Therapeutics and Innovation

July 28, 2025

Article

Huntsman Cancer Foundation and Sigma Chi International Fraternity announced a $31 million pledge for the Sigma Chi Center for Advanced Therapeutics.

Beckerle Steps Down After 20 Years of Distinguished Service as CEO

July 24, 2025

Article

The CEO of Huntsman Cancer Institute is stepping down after holding the role since 2006.

Interdisciplinary Grants Awarded for Cancer-Focused Engineering Projects

July 21, 2025

Article

Innovative engineering teams at Huntsman Cancer Institute tackle cancer treatment challenges through collaborative grants.

Dr Maese on the Use of Pediatric-Inspired Regimens in AYA and Adult ALL

July 18, 2025

Video

Luke Maese, DO, discusses how the evolution of AYA and adult ALL management may be inspired by treatment protocols used in the pediatric population.

Dr Schmidt on the Role of Minimally Invasive and Robotic Modalities in Bladder Cancer

June 09, 2025

Video

Bogdana Schmidt, MD, MPH, discusses the role of minimally invasive and robotic strategies for the treatment of patients with bladder cancer.

Alana Welm, PhD, Named Chair of Oncological Sciences in the Spencer Fox Eccles School of Medicine at the University of Utah

May 23, 2025

Article

Alana Welm, PhD, is now the chair of the Department of Oncological Sciences in the Spencer Fox Eccles School of Medicine at the University of Utah.

The ‘Bar Is High’ to Usurp BCG, but Novel Therapies Could Drive Change in Bladder Cancer Management

May 20, 2025

Article

Bogdana Schmidt, MD, MPH, discussed FDA-approved BCG-refractory treatments and recent shifts in BCG-naive NMIBC management.

First Successful Allogeneic Stem Cell Transplant Using Deceased Donor in Blood Cancer Clinical Trial

May 15, 2025

Article

Huntsman Cancer Institute pioneers a clinical trial using deceased donor stem cells, expanding transplant options for patients with aggressive blood cancers.

Researcher Bruce Edgar Elected to National Academy of Sciences

May 08, 2025

Article

Bruce Edgar, PhD, researcher at Huntsman Cancer Institute, has been elected as a member to the National Academy of Sciences.

Dr Schmidt on FDA-Approved Bladder-Sparing Therapies in BCG-Refractory NMIBC

May 06, 2025

Video

Bogdana Schmidt, MD, MPH, highlights FDA approved bladder-sparing therapies for patients with BCG-refractory non–muscle-invasive bladder cancer.

New Drug Therapy Combination Shows Promise For Advanced Melanoma Patients

March 28, 2025

Article

A federally funded research team is testing a new combination drug therapy that could both treat and prevent melanoma metastasis to the brain.

Anna Parks Receives American Society of Hematology Junior Faculty Scholar Award

February 24, 2025

Article

Anna Parks, MD, Huntsman Cancer Institute investigator, has been awarded the ASH Junior Faculty Scholar Award.